# HAIN earnings call intelligence

LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/HAIN) · [Earnings tab](https://www.lopjlb.com/stock/HAIN?tab=earnings)

Updated: 2026-09-17T06:12:34

Quarters analyzed: 8

## Cross-quarter narrative

Across 8 calls for HAIN, management tone moved from +0.00 (2025 Q1) to +0.00 (2027 Q1). Latest guidance stance: vague. Latest desk line: n/a

## Latest CallCard · Q1

**Guidance:** vague

**Tone:** mgmt 0 · Q&A pressure 0 · divergence 0

## Quarter one-liners

- **2027 Q1:** —
- **2026 Q3:** HAIN Q3: organic sales -6% (Intl -8%), but strong cash gen, $155M debt paydown from snacks divestiture, adj EBITDA $26M, margins up sequentially; innovation driving share gains in NA core (tea, yogurt, baby), Intl challenges in baby, spreads, soup but pipeline accelerating; strategic review ongoing.
- **2026 Q2:** Hain Celestial sells NA snacks for $115M to deleverage, focuses on tea/yogurt/baby core; Q2 organic sales -7% but flat ex-hotspots; EBITDA $24M; back-half improvement expected.
- **2026 Q1:** Hain reported Q1 2026 sales and earnings roughly in line with expectations despite a 6% organic decline, highlighted cost cuts, SKU reductions and new product launches, and said the second half should see moderated declines and margin improvement.
- **2025 Q4:** Hain Celestial reports a disappointing Q4 with sales shortfalls, but outlines aggressive cost cuts, restructuring, and a robust innovation pipeline to stabilize sales and improve profitability.
- **2025 Q3:** Hain Celestial reports disappointing Q3 with 5% organic sales decline, EBITDA down 23%; announces CEO transition and strategic portfolio review with Goldman Sachs; no FY2026 guidance given.
- **2025 Q2:** Hain posted a weak Q2 with 7% sales decline but generated strong cash flow, cut debt and sees upside from infant formula recovery, distribution gains and new innovations, while flagging macro volatility and snack marketing execution risk.
- **2025 Q1:** —

## Theme arcs

- **Management tone** (stable): Δ mgmt=+0.00

## Fear persistence

- **macro volatility** [resolved]: 2025 Q2
- **snack execution** [resolved]: 2025 Q2
- **supply constraints** [resolved]: 2025 Q2
- **ingredient differentiation** [resolved]: 2025 Q2
- **personal‑care divestiture timing** [resolved]: 2025 Q2
- **sales shortfall** [resolved]: 2025 Q4
- **international weather impact** [resolved]: 2025 Q4
- **cost structure** [resolved]: 2025 Q4
- **pricing lag** [resolved]: 2025 Q4
- **innovation lag** [resolved]: 2025 Q4

## Guidance path

2025 Q1:vague → 2025 Q2:maintained → 2025 Q3:withdrawn → 2025 Q4:vague → 2026 Q1:vague → 2026 Q2:vague → 2026 Q3:vague → 2027 Q1:vague

---

Research context only. Not personalized investment advice.

API: `GET /bff/api/bigfive/earnings-intel/HAIN`